학술논문

PB2133: ASSESSING SAFETY, TOLERABILITY, AND EFFICACY OF SUBCUTANEOUS EPCORITAMAB IN NOVEL COMBINATIONS WITH ANTI‐NEOPLASTIC AGENTS IN PATIENTS WITH NON‐HODGKIN LYMPHOMA IN A PHASE 1B/2, OPEN‐LABEL STUDY.
Document Type
Article
Source
HemaSphere; 2022 Supplement 3, Vol. 6, p2004-2005, 2p
Subject
Language
ISSN
25729241